Gilead Sciences Inc. (NASDAQ: GILD) announced the completion of its acquisition of Tubulis GmbH, a Germany-based biotechnology company developing antibody-drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE